Phlow in the USAspending register. Phlow shows 2 federal contracts with $702,694,676 obligated in the USAspending register, from April 2020 to May 2020, across 1 agency.
Assay record ASY-US-0WRBPZ41HS · Cite as: Assay Systems, “Phlow in the USAspending register”, https://assay-systems.com/register/us/phlow/
Phlow shows 2 federal contracts with $702,694,676 obligated in the USAspending register, from April 2020 to May 2020, across 1 agency.
No contract is recorded for Phlow since January 2024. The last entry is dated May 2020.
Your line in the register: Drugs and biologicals (6505)
Since January 2024 the line carries 158,923 contracts with $28,207,463,721 obligated from 12 agencies.
514 suppliers share it. Phlow holds no contract in it since January 2024.
11 agencies have bought this line since 2024 and have never held a contract with Phlow: 157,938 contracts with $26,436,623,565 obligated.
One of those agencies alone accounts for 2,253 of them, with $18,871,511,399 obligated.
1,882 contracts since 2024, with $393,644,990 obligated, went to the only supplier that applied.
1,494 more, with $630,079,768 obligated, were awarded directly, with no competition at all.
Phlow was the supplier on none of them.
111,067 of the 157,938 contracts in the 11 agencies were under $15,000 each, $311,122,614 in total. Below $15,000 the Federal Acquisition Regulation allows an agency to buy without soliciting competitive quotations.
227 contracts in the line, with $707,335,355 obligated, reach their end dates by September 2027.
139 of them, with $71,368,147 obligated, end in the same month, September 2026.
189 of them, with $102,296,602 obligated, sit in the 11 agencies that have never bought from Phlow.
From $3,579,627,887 in 2022 and 2023 to $7,051,163,185 in 2024 to 2026, 97 percent. It sells the same line.
Assay Systems reads large volumes of public procurement data and returns commercial intelligence.
The extract for Phlow can be prepared in the shortest time. It will name the 11 agencies and the buying office on each of the 157,938 contracts. For each contract it will name who holds it now, the obligated amount, the contract number and the end date, and the notices behind every figure.
MCKESSON CORPORATION: 3,527 contracts worth $19,016,360,902 from 4 agencies since 2024, up 7 percent on 2022 to 2023.
AMERISOURCEBERGEN DRUG CORP: 119,685 contracts worth $7,051,163,185 from 2 agencies since 2024, up 97 percent on 2022 to 2023.
ALVOGEN, INC.: 3 contracts worth $284,780,592 from 2 agencies since 2024.
The extract for this line names every department and buying office behind the figures above, who holds each contract now, its value, contract number and end date, and the notices behind every figure.
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.